file:///C:/Users/USER/Downloads/Eli_Lilly__The_Evista_Project.pdf
Eli Lilly Case

1. What is a “heavyweight project team” and how does it differ from the traditional
   approach used by Eli Lilly?
2. What is your assessment of the performance of two heavyweight teams described in
   the case? What factors contributed most to these performance results (choose the
   factors and the performance metrics that you think are most important)? In the
   pharmaceutical context, how far back in the development process should
   heavyweight teams be deployed? Why?
3. Is the “heavyweight” project team an approach that you would recommend to Lilly
   for purposes of commercializing the Evista Project? Why or why not?When making a
   specific choice (for question 3), you need to (i) argue for your choice, and (ii) actively think ofcounter-arguments, and how the concerns raised by these counter-arguments can be
   addressed